About the project
PwC’s Deals and Tax Advisory teams have successfully supported another cross-border transaction in the healthcare sector.
Asker Healthcare Group has signed an agreement to acquire 100% of the shares in Ambercell Solutions UAB (“Ambercell”), a leading provider of medtech solutions and medical consumables in the Baltic region.
Founded in Lithuania, Ambercell supplies therapy- and procedure-specific packs and a broad range of medical products, technologies, and clinical solutions to healthcare providers across Lithuania, Latvia, and Estonia. Through its proprietary supply chain management platform, the company helps healthcare institutions streamline procurement and improve operational efficiency. Ambercell employs 45 professionals and generated approximately EUR 22 million in revenue over the past year.
PwC’s Baltic team acted as adviser to Asker Healthcare Group and provided comprehensive financial and tax due diligence services, as well as support throughout the share purchase agreement (SPA) preparation and negotiation process.
The transaction remains subject to customary regulatory approvals and is expected to be completed in the fourth quarter of 2026.
PwC team
- Teet Tender, Country managing partner, PwC Estonia
- Allar Karu, Senior Manager in Deals, PwC Estonia
- Petras Misiūnas, Head of Deals, PwC Lithuania
- Violeta Kirilovaitė, Manager in Deals, PwC Lithuania
- Lukas Petkevičius, Senior Associate in Deals, PwC Lithuania
- Rainers Bumanis, Senior Associate in Deals, PwC Latvia
- Nerijus Nedzinskas, Country managing partner, PwC Lithuania
- Ingrida Kemežienė, Senior Manager in Tax and Legal Services, PwC Lithuania
- Tomas Janeika, Senior Associate in Tax and Legal Services, PwC Lithuania
We congratulate Asker Healthcare Group and all parties involved on the successful signing of the transaction and are pleased to have contributed to this important milestone.
For more information about the acquisition, read Asker Healthcare Group’s announcement:
Contact us
